Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
Dermaliq Therapeutics Announces First Patient Dosed in Phase 1b/2 Trial Evaluating DLQ02 for Treatment of Plaque Psoriasis - Novaliq
Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products.
This website is hosted with 1&1 IONOS SE, which reserves the following IP addresses for novaliq.de: 217.160.0.203. Moreover, DNS used with this website include ns1027.ui-dns.org, ns1047.ui-dns.com, ns1049.ui-dns.de, ns1101.ui-dns.biz.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns1027.ui-dns.org
ns1047.ui-dns.com
ns1049.ui-dns.de
ns1101.ui-dns.biz
{{value}}
1970-01-01
1970-01-01
Hostmaster EINSUNDEINS (1&1 Internet AG)
DENIC eG
hostmaster@1und1.de
{{value}}
The registrar of novaliq.de is DENIC eG. According to open source data, you can reach the owner at hostmaster@1und1.de but please make sure you have a good reason for unsolicited messages.
N/A
N/A
N/A
N/A
N/A
N/A
N/A
133
N/A
N/A